Jacek Olczak, Philip Morris International CEO, joins CNBC's 'Money Movers' to discuss the company's most recent earnings.

The U.S. Food and Drug Administration (FDA) recently approved the marketing of 20 Zyn nicotine pouches, marking the first time nicotine pouches ...

Philip Morris International Inc. soared to a record after reporting better-than-expected profit driven by sales of Zyn ...

Philip Morris International Inc.'s stock touched an record high on Thursday after it issued a profit outlook that topped Wall Street analyst expectations on strength in its smokeless-tobacco products.

Philip Morris International Inc. issued a profit outlook that topped Wall Street analyst expectations on strength in its smokeless-tobacco products, sending shares of the company higher in premarket ...

RICHMOND, Va. The U.S. Food and Drug Administration (FDA) today authorized ZYN nicotine pouches making ZYN the first and only authorized nicotine pouch in the United States. The FDA’s ...

Philip Morris International Inc. (PMI) (NYSE: PM) today announces its 2024 fourth-quarter and full-year results.1 "2024 was a remarkable year ...

Social media posters speculate that Donald Trump’s pick for US health secretary could have been using Zyn product ...

Trusted resource of information on Addiction that includes articles, news, videos, animations, quizzes, calculators and drugs ...

The recent decision by the US Food and Drug Administration (FDA) to authorise the marketing of 20 ZYN nicotine pouches has ...

The pouches have been available for more than a decade as FDA reviewed company data intended to show the products can serve as an alternative to cigarettes and other traditional tobacco products. The ...